Why oncology needs dosing redesign.
Sirj Goswami, PhD
Advertisement
Sirj Goswami, PhD, CEO, co-founder of InsightRX
Articles by Sirj Goswami, PhD
Continued embrace of precision dosing will reduce costs and optimize clinical outcomes.
Advertisement
Latest Updated Articles
Understanding Project OptimusPublished: July 13th 2022 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
